Comparative Pharmacology
Head-to-head clinical analysis: DYNA HEX 4 versus TETREX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DYNA HEX 4 versus TETREX.
DYNA-HEX 4 vs TETREX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate is a cationic bisbiguanide antiseptic and disinfectant that disrupts microbial cell membranes, causing leakage of cytoplasmic contents and cell death.
Tetracycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing aminoacyl-tRNA from binding to the A site.
1-2 tablets (200-400 mg chlorhexidine gluconate) sublingually every 6 hours as needed for symptom relief.
250-500 mg orally every 6 hours or 500 mg to 1 g intravenously every 6-12 hours, not to exceed 4 g/day.
None Documented
None Documented
Terminal elimination half-life: 2.5-3.5 hours (prolonged in renal impairment).
Terminal elimination half-life: 6-11 hours (mean 8 hours); prolonged in renal impairment (up to 20 hours).
Renal: 60-80% unchanged; Fecal: 20-40% as metabolites.
Renal: 60% unchanged; biliary/fecal: 40% (mainly as glucuronide conjugates).
Category C
Category C
Tetracycline Antibiotic
Tetracycline Antibiotic